Immatics (IMTX) Minority Interest (2019 - 2020)
Immatics (IMTX) posted Minority Interest of $559541.7 for Q2 2020, down 50.44% sequentially from $1.1 million in Q4 2019.
Immatics (IMTX) Minority Interest (2019 - 2020) Analysis & Trends
Immatics has reported Minority Interest for 2 years, with the latest figure at $559541.7 in Q2 2020.
- Quarterly Minority Interest changed N/A year-over-year to $559541.7 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $559541.7 (changed N/A YoY) and the FY2019 annual result came in at $1.1 million, changed N/A from the prior year.
- Minority Interest eased to $559541.7 in Q2 2020 per IMTX's latest filing, from $1.1 million in the prior quarter.
- Over five years, Minority Interest peaked at $1.1 million in Q4 2019 and troughed at $559541.7 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 559,541.75 |
| Dec 31, 2019 | 1.13 Mn |